PKM2 also has a dimeric form in cancer, which has a nuclear localization sequence allowing PKM2 to act as a co-transcription factor and kinase stimulating HIF-1α expression and activity (de Wit et al., 2016). The gene discussed is HIF1A; the disease is cancer.